Skip to main content

COVID-19 & cancer


Woman with drip and mask

30-08-2023 | COVID-19 | News

Cancer treatment linked to increased risk for COVID-19-related VTE

An analysis of the CCC19 registry has demonstrated a significant link between receipt of anticancer therapies within 3 months of a COVID-19 diagnosis and an elevated risk for venous thromboembolism

Antibodies attacking SARS-CoV-2 virus, the conceptual 3D illustration for COVID-19 treatment, diagnosis and prevention

10-01-2023 | COVID-19 | News

Antibody testing may identify cancer patients at increased risk of COVID-19 breakthrough infections

A Canadian population-based study has confirmed that people with cancer have an increased risk of breakthrough COVID-19 infection after vaccination, while UK research points to the feasibility of SARS-CoV-2 antibody testing to identify those with the lowest level of vaccine-derived protection.

Positive test result by using rapid test device for COVID-19

07-11-2022 | COVID-19 | News

Anticancer therapy tied to worse COVID-19 outcomes in people receiving immunosuppressive agents

People with cancer receiving immunotherapy or other anticancer treatments are at increased risk for adverse COVID-19 outcomes if they are also receiving immunosuppressive therapy, suggests a registry-based cohort study.